Category : COVID-19 | Sub Category : Lockdown Posted on 2020-04-29 23:39:00
While the
developed world will no doubt manage to claw their way out of the COVID-19
crisis, India has always been the perpetual wild card. It is here that the
world has most feared the hammer will hit hardest. And yet, if we look at the
numbers, however academically brutal it may sound, the story isn’t playing out
as badly as we expected, so far.
India which is
not a part of the first world countries was expected to be affected by coronavirus
extensively, as it is the second most populated country. India is fighting
efficiently against the pandemic situation, while countries like the USA and
Italy are facing difficulty in managing the steep growth of the death curve.
India was the
first nation to essentially shut its borders cancelling visas and denying entry
to all but a few selected foreigners. Some states such as Kerala are beginning
to beef up internal borders checking the temperature of passengers in the car
and screening people on trains. Demographics also work to India’s advantage.
The population here is considerably younger than in the countries. As from the
data of WHO, it is seen that young patients have a better chance of surviving
the viral attack.
The Indian
government has taken the best initiative of a total countrywide lockdown from
25th March and it has been extended till 3rd May. Due to this lockdown, India
has been able to control the outbreak of the virus for a huge percentage. The
government has ensured the unhampered supply of essential commodities and
medicines for its common people. Various funds like PM CARES and West Bengal
State Emergency Relief Fund has been created which will be used for combat,
containment and relief efforts against the coronavirus outbreak.
Presently it is
seen that India’s malarial drug hydroxychloroquine is powering the global
coronavirus war and ever-rising global demand for the antimalarial drug
hydroxychloroquine. The country meets 82-85% of the medicine’s requirement
worldwide and has agreed to export it to the USA and Brazil among other nations
after a request from the President. Zydus Cadila and Ipca Laboratories are the
biggest hydroxychloroquine manufacturers in India.
By: Soumyadeep Chattopadhyay, B.Pharm 2nd Year, 4th Semester